Berlin
Germany
48
2024-03-14
The entities that hold a legal rights for patent applications filed by inventor Briem Hans:
Hans Briem from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
2-Methyl-Quinazolines
#2 | 2023-01-262-METHYL-AZA-QUINAZOLINES
#3 | 2022-09-012-METHYL-AZA-QUINAZOLINES
#4 | 2022-07-282-METHYL-QUINAZOLINES
#5 | 2020-12-102-(morpholin-4-yl)-1,7-naphthyridines
#6 | 2020-08-06Substituted Pyrrolopyridine-Derivatives
#7 | 2020-07-09HETERO-1,5,6,7-TETRAHYDRO-4H-INDOL-4-ONES
#8 | 2019-09-19Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
#9 | 2019-02-14Heteroarylbenzimidazole compounds
#10 | 2018-09-132-(morpholin-4-yl)-1,7-naphthyridines
#11 | 2018-08-091H-pyrrol-3-amines
#12 | 2018-06-073-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
#13 | 2018-01-184H-pyrrolo[3,2-C]pyridin-4-one derivatives
#14 | 2017-10-26BENZYL SUBSTITUTED INDAZOLES AS BUB1 KINASE INHIBITORS
#15 | 2017-10-05DIAMINOHETEROARYL SUBSTITUTED INDAZOLES
#16 | 2017-09-28BENZYL SUBSTITUTED INDAZOLES
#17 | 2017-09-28BENZYL SUBSTITUTED INDAZOLES AS BUB1 KINASE INHIBITORS
#18 | 2017-09-28HETEROARYL SUBSTITUTED INDAZOLES
#19 | 2017-09-28SUBSTITUTED CYCLOALKENOPYRAZOLES AS BUB1 INHIBITORS FOR THE TREATMENT OF CANCER
#20 | 2017-09-28Benzyl substituted indazoles as BUB1 inhibitors
#21 | 2017-09-14Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
#22 | 2017-09-07Substituted pyridobenzodiazepinone-derivatives and use thereof
#23 | 2017-08-032-(morpholin-4-yl)-1,7-naphthyridines
#24 | 2017-04-133-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
#25 | 2016-11-10Heteroaryl substituted pyrazoles
#26 | 2016-10-13Substituted triazolopyridines
#27 | 2016-10-062-(morpholin-4-yl)-1,7-naphthyridines
#28 | 2016-09-15SUBSTITUTED TRIAZOLOPYRIDINES HAVING ACTIVITY AS MPS-1 INHIBITORS
#29 | 2016-07-21NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER
#30 | 2016-06-16HETEROARYL SUBSTITUTED PYRAZOLES
#31 | 2016-06-02Substituted Benzylpyrazoles
#32 | 2016-05-26HETEROARYL SUBSTITUTED PYRAZOLES
#33 | 2016-05-26Substituted benzylpyrazoles
#34 | 2016-05-26Heteroaryl substituted pyrazoles
#35 | 2016-02-25DIAMINOHETEROARYL SUBSTITUTED INDAZOLES
#36 | 2016-02-183-HETEROARYL SUBSTITUTED INDAZOLES
#37 | 2016-02-18HETEROARYL SUBSTITUTED INDAZOLES
#38 | 2015-12-24Imidazopyridazines as Akt kinase inhibitors
#39 | 2015-05-21Substituted cycloalkenopyrazoles as BUB1 inhibitors for the treatment of cancer
#40 | 2014-10-23Substituted benzylpyrazoles
#41 | 2014-09-04Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
#42 | 2014-05-01TRIAZOLOPYRIDINES
#43 | 2014-04-24Imidazopyridazines as Akt kinase inhibitors
#44 | 2013-06-20Substituted triazolopyridines
#45 | 2013-05-23Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
#46 | 2012-12-27Substituted triazolopyridines
#47 | 2012-12-27Triazolopyridines
#48 | 2010-10-14Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
263750 ⎘